bioAffinity Technologies closes $3.2M public offering of common stock and pre-funded warrants

bioAffinity Technologies, Inc.

Offering of 1,040,000 shares at $0.80 each and pre-funded warrants for 2,960,000 shares at $0.793 each.
Gross proceeds of $3.2M before fees; net proceeds for working capital and general corporate purposes.
Post-closing common shares outstanding: 6,283,061.
Placement agent WallachBeth Capital LLC received 7.5% fee plus $120,000 expense reimbursement.
Company subject to 30-day lock-up on equity issuances and 3-month ban on variable-rate transactions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.